Part of the war on drugs is the desire to have as much of a monopoly on altered perceptions as possible, to be able to control its application from a top-down operational level.
Huxley predicted that the technocrats would use drugs to alter perception in the ruled, to make people "happy" when they should not be happy.
To reinforce and guide the effects of the drugs, we have therapy and psychiatry and mass media and staged events—the peanut butter and chocolate of MKUltra fuckery, the bounty of all that research, ways to weaponize trauma against you and others.
Psych drugs and tranny drugs are all part of the corporate state's way of controlling the White public and opening new markets for products that are cheap to produce.
If SSRIs and lithium and so on were cut off from the public for a month, there would not be a United States government anymore—and that's not just because those drugs are addictive.
💊 SSRI Risks & Effects — Streamlined Fact Summary
📊 Violent behavior (15–24)
Swedish registry study of ~856k people reported a 43% increase in violent-crime convictions during SSRI-treated periods in this age group.
📊 Suicidal thoughts/behaviors (youth)
Antidepressant trials in children and adolescents show ~4% suicidal ideation/behavior on drug vs ~2% on placebo.
📊 Bipolar switching
In bipolar populations, antidepressant-associated mania/hypomania emergence appears in ~15–40% of reported clinical samples.
General-population lifetime bipolar prevalence sits around 1–4%.
📊 Emotional blunting
Surveys and clinical studies report ~40–60% experience reduced emotional intensity or authenticity.
📊 Motivation/affect dampening
Reported as part of emotional blunting: muted positive/negative affect and lowered drive.
📊 Sexual dysfunction
Large outpatient studies: ~50–70% incidence depending on drug and measurement method.
📊 Pregnancy risks
Some cohort and registry studies show small absolute increases in specific defects (e.g., ~0.5% → ~0.9% for certain cardiac septal defects).
Paroxetine shows the most consistent signal in older data.
📊 Withdrawal / discontinuation
Patient surveys: ~50–60% report withdrawal symptoms.
Meta-analysis of controlled trials: ~15%.
📊 Common early side effects
Akathisia, agitation, anxiety spikes, insomnia, palpitations.
📊 Pharmacogenetics
CYP2D6 and CYP2C19 variants affect SSRI metabolism and dosing response; published clinical dosing guidelines exist.
RT: https://noauthority.social/users/PNS/statuses/116112897856181185
Huxley predicted that the technocrats would use drugs to alter perception in the ruled, to make people "happy" when they should not be happy.
To reinforce and guide the effects of the drugs, we have therapy and psychiatry and mass media and staged events—the peanut butter and chocolate of MKUltra fuckery, the bounty of all that research, ways to weaponize trauma against you and others.
Psych drugs and tranny drugs are all part of the corporate state's way of controlling the White public and opening new markets for products that are cheap to produce.
If SSRIs and lithium and so on were cut off from the public for a month, there would not be a United States government anymore—and that's not just because those drugs are addictive.
💊 SSRI Risks & Effects — Streamlined Fact Summary
📊 Violent behavior (15–24)
Swedish registry study of ~856k people reported a 43% increase in violent-crime convictions during SSRI-treated periods in this age group.
📊 Suicidal thoughts/behaviors (youth)
Antidepressant trials in children and adolescents show ~4% suicidal ideation/behavior on drug vs ~2% on placebo.
📊 Bipolar switching
In bipolar populations, antidepressant-associated mania/hypomania emergence appears in ~15–40% of reported clinical samples.
General-population lifetime bipolar prevalence sits around 1–4%.
📊 Emotional blunting
Surveys and clinical studies report ~40–60% experience reduced emotional intensity or authenticity.
📊 Motivation/affect dampening
Reported as part of emotional blunting: muted positive/negative affect and lowered drive.
📊 Sexual dysfunction
Large outpatient studies: ~50–70% incidence depending on drug and measurement method.
📊 Pregnancy risks
Some cohort and registry studies show small absolute increases in specific defects (e.g., ~0.5% → ~0.9% for certain cardiac septal defects).
Paroxetine shows the most consistent signal in older data.
📊 Withdrawal / discontinuation
Patient surveys: ~50–60% report withdrawal symptoms.
Meta-analysis of controlled trials: ~15%.
📊 Common early side effects
Akathisia, agitation, anxiety spikes, insomnia, palpitations.
📊 Pharmacogenetics
CYP2D6 and CYP2C19 variants affect SSRI metabolism and dosing response; published clinical dosing guidelines exist.
RT: https://noauthority.social/users/PNS/statuses/116112897856181185
